Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

The Price Elasticity of Specialty Drug Use: Evidence from Cancer Patients in Medicare Part D.

Jung JK, Feldman R, McBean AM.

Forum Health Econ Policy. 2017 Dec;20(2). pii: 20160007. doi: 10.1515/fhep-2016-0007. Epub 2017 May 26.

2.

Socioeconomic Differences in Use of Low-Value Cancer Screenings and Distributional Effects in Medicare.

Xu WY, Jung JK.

Health Serv Res. 2017 Oct;52(5):1772-1793. doi: 10.1111/1475-6773.12559. Epub 2016 Sep 13.

3.

Coverage for hepatitis C drugs in Medicare Part D.

Jung JK, Feldman R, Cheong C, Du P, Leslie D.

Am J Manag Care. 2016 May;22(6 Spec No.):SP220-6.

4.

The Effect of Publicized Quality Information on Home Health Agency Choice.

Jung JK, Wu B, Kim H, Polsky D.

Med Care Res Rev. 2016 Dec;73(6):703-723. Epub 2015 Dec 30.

5.

New entrants' practice patterns in Medicare home health care after the prospective payment system revision in 2008.

Kim H, Jung JK.

Healthc (Amst). 2015 Sep;3(3):135-41. doi: 10.1016/j.hjdsi.2015.06.005. Epub 2015 Jun 26.

PMID:
26384224

Supplemental Content

Loading ...
Support Center